Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

Completed · Phase 4

Conditions studied: Macula Thickening

In brief

The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.

Key facts

Study ID

NCT00433225

Run by

Innovative Medical

Last updated by the study team

2007-09-10

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females > 50 years old
• Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
• Likely to complete all study visits and able to provide informed consent
• Visual potential of 20/25 or better

You may not qualify if…

• · Prior use of topical ketorolac
• Known contraindications to any study medication or ingredients
• Active ocular diseases or uncontrolled systemic disease
• Active ocular allergies

Where it is running

• Ophthalmic Consultants of Long Island — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.